Deakin University
Browse

File(s) not publicly available

Engineering of the VPAC2-Selective agonist BAY 55-9837 for the treatment of type 2 diabetes

journal contribution
posted on 2024-09-29, 23:50 authored by C Pan, S Yung, F Dela Cruz, S Hamren, J Zhu, L Lemoine, YI Li, M Nori, XB Peng, T Claus, Linda SweetLinda Sweet, A Shanafelt, M Tsutsumi
Engineering of the VPAC2-Selective agonist BAY 55-9837 for the treatment of type 2 diabetes

History

Journal

DIABETES

Volume

50

Pagination

A230-A230

ISSN

0012-1797

Language

English

Publication classification

E3.1 Extract of paper

Publisher

AMER DIABETES ASSOC

Usage metrics

    Research Publications

    Categories

    Keywords

    Science & TechnologyLife Sciences & BiomedicineEndocrinology & Metabolism

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC